+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Global Empty Capsules Market set to grow to $2.8bn by 2025” says new Visiongain report

23 January 2020
Pharma

Visiongain has launched a new pharma report Global Empty Capsules Market Report: Gelatin Capsules, Non-gelatin Capsules, Pig Skin Gelatin, Bovine Derived Gelatin, Bone Meal Gelatin, Hydroxypropyl Methyl Cellulose (HPMC), Pullulan, Starch Material, Antibiotic & Antibacterial Drugs, Vitamins & Dietary Supplements, Cough & Cold Preparations, Anti-inflammatory Drugs, Cardiovascular Drugs, Antacid & Antiflatulent Drugs, Antianemic Drugs, Pharmaceutical Industry, Neutraceutical Industry, Cosmetics Industry, Clinical Research Laboratories.

The empty capsules market is a highly competitive and diverse market with immense potential for growth. The growth drivers of this market are ageing population, increasing applications in the pharmaceutical and nutraceutical industries, increasing demand for non-gelatin/HPMC capsules in nutraceutical industry, and market development in emerging countries due to low manufacturing advantage.

The lead analyst of the report commented "The non-gelatin capsules segment is estimated to grow at the highest CAGR during the forecast period. Strict government regulations, dietary sensitivity of patients, and drug incompatibilities with gelatin capsules are the major factors driving the growth of the non-gelatin capsules segment. the growing demand for non-gelatin-based capsules and the rapidly expanding pharmaceutical industry in emerging countries such as India and China offer significant growth opportunities for players in this market."

Leading companies featured in the report include ACG Worldwide, Bright Pharmacaps Inc., CapsCanada Corporation, Capsugel (Lonza), Healthcaps India Ltd., Medicaps Ltd., Natural Capsules Limited and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

21 September 2023

Read

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

14 September 2023

Read

Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

13 September 2023

Read

Visiongain Publishes Immuno-Oncology Clinical Trials Market Report 2023-2033

Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.

11 September 2023

Read